Skip to main content

Is an Enterra Therapy program viable for your institution?

(0:00:56)

Dr. Eva Alsheik, Gastroenterologist at Henry Ford Health, shares how a strong commitment to advancing care for patients experiencing nausea and vomiting from gastroparesis led her institution to support and invest in a gastric electrical stimulation program with Enterra Therapy.

Watch video

Eva Alsheik, MD

Gastroenterologist
Henry Ford Health

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?